Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study

导出原文传递

翻译打印收藏纠错

作者： García-González,M.J. ^[1] ; DeMora-Martín,M. ^[2] ; López-Fernández,S. ^[3] ; López-Díaz,J. ^[4] ; Martínez-Sellés,M. ^[5] ; Romero-García,J. ^[6] ; Cordero,M. ^[7] ; Lara-Padrón,A. ^[8] ; Marrero-Rodríguez,F. ; DelMarGarcía-Saiz,M. ; Aldea-Perona,A.

作者单位： Department of Cardiology, Hospital Virgen de la Nieves, Granada, Spain ^[1] Department of Clinical Pharmacology, Hospital Universitario de Canarias, La Laguna, Sta. Cruz de ^[2] Department of Cardiology, Fundación Jiménez Díaz, Madrid, Spain ^[3] Clinical Trials Unit, Fundación Rafael Clavijo para la Investigación Biomédica, Hospital ^[4] Department of Cardiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain ^[5] Department of Cardiology, Hospital Regional Carlos Haya, Málaga, Spain ^[6] Department of Cardiology, Hospital Universitario de Canarias, Ctra. La Cuesta - Taco, 38320 San ^[7] Department of Cardiology, Hospital General Universitario Gregorio Mara?ón, Universidad Europea ^[8]

关键词 Advanced heart failure Efficacy Levosimendan Outpatients Repeated administration Safety

发布时间 2014-03-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交